Skip to content
Search

Latest Stories

FDA finds Indian company's eye drops that caused deaths violated safety norms

EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears, manufactured in India by Global Pharma, have been associated with a fatal outbreak of drug-resistant infections in the US

FDA finds Indian company's eye drops that caused deaths violated safety norms

According to the top regulator in the US, the manufacturer of eye drops based in India, which has been linked to three deaths and severe infections, had breached multiple safety regulations.

The Food and Drug Administration (FDA) conducted an inspection of Global Pharma's facility in Chennai, India, and released a report last week.


The company recalled the eye drops in February after a recommendation from the FDA. The FDA also banned the import of the product.

Two brands of eye drops – EzriCare Artificial Tears and Delsam Pharma's Artificial Tears, which were manufactured in India by Global Pharma and imported to the US, have been associated with a fatal outbreak of drug-resistant infections in the US.

In March, the Centres for Disease Control and Prevention (CDC) in the US reported that 68 individuals across 16 states had been diagnosed with a rare type of Pseudomonas aeruginosa, which can lead to severe infections, particularly in people with weakened immune systems.

This drug-resistant strain had not been discovered in the US prior to the most recent epidemic.

As per the BBC report in March, besides the fatalities, eight patients experienced a loss of vision, while four had to undergo eye surgery to remove their eye.

In February, EzriCare Artificial Tears stated on its website that they had been contacting customers to discourage them from using the product, to the best of their abilities.

However, the company claimed to not be involved in the actual production of the eye drops, despite marketing them.

Initially, the recall was limited to EzriCare Artificial Tears Lubricant and Delsam Pharma Artificial Tears Lubricant eye drops, but it was subsequently expanded to include a Delsam Pharma eye ointment.

Additionally, according to the agency's report, during an 11-day inspection of the Global Pharma plant in India, which started on February 20, the FDA identified multiple infringements of sterilisation and hygiene protocols.

The sterile manufacturing environment had several items that were not adequately cleaned, including a bowl with a greasy deposit.

The FDA's report also stated that surfaces that came into touch with drug packaging were not appropriately cleaned, decontaminated, sanitised or sterilised.

The CDC also expressed concern that the bacteria associated with the contaminated eye drops could establish itself in the US healthcare system, a report in The New York Times on Monday (03) informed.

The CDC had previously advised individuals who had used the recalled products and were experiencing symptoms to consult a physician.

Symptoms included a discharge from the eye that was yellow, green, or clear, discomfort or pain, redness, blurry vision, and heightened sensitivity to light.

More For You

uk-railways-iStock

The package includes £415 million to upgrade the rail line between Manchester, Huddersfield, Leeds, and York, a route affected by delays and disruptions. (Representational image: iStock)

iStock

Government announces £1.7 bn transport investment for the North

THE GOVERNMENT has announced a £1.7 billion investment to improve transport infrastructure across the North, focusing on buses, roads, and rail.

The funding aims to upgrade key routes and improve connectivity across the region.

Keep ReadingShow less
Keir-Starmer-Getty

Keir Starmer’s communications chief has resigned after nine months in Downing Street. (Photo: Getty Images)

Getty Images

Starmer’s communications chief Matthew Doyle resigns after nine months

KEIR STARMER’s communications chief, Matthew Doyle, has resigned after nine months in Downing Street. Doyle, a Labour veteran who previously worked for Tony Blair, joined Starmer’s team as communications director four years ago when the party was in opposition.

His departure follows that of Sue Gray, Starmer’s former chief of staff, who left in the autumn. Doyle’s exit is expected to lead to the promotions of James Lyons to director of communications (strategy) and Steph Driver to director of communications (delivery), according to the BBC.

Keep ReadingShow less
Lakshmi-Mittal-Getty

Mittal, who built his steel business over five decades, moved to the UK in 1995. (Photo: Getty Images)

Getty Images

Lakshmi Mittal may leave UK after non-dom tax abolition: report

STEEL tycoon Lakshmi Mittal is considering leaving the UK following the government’s decision to abolish the non-domiciled tax status. The move would make him one of the most prominent entrepreneurs to leave due to the tax reform.

Mittal, who has lived in the UK for three decades, has informed associates that his departure is likely due to Labour’s decision to end the non-dom regime, which allowed certain residents to avoid paying UK tax on foreign income.

Keep ReadingShow less
King Charles

The palace said in a statement that after receiving scheduled treatment in the morning, the king had 'temporary side effects that required a short period of observation in hospital.' (Photo: Getty Images)

Getty Images

King Charles cancels engagements after cancer treatment side effects

KING CHARLES has postponed his engagements for Thursday and Friday after experiencing side effects from his ongoing cancer treatment, Buckingham Palace announced.

The palace said in a statement that after receiving scheduled treatment in the morning, the king had "temporary side effects that required a short period of observation in hospital."

Keep ReadingShow less
Salman Rushdie to release first major work since stabbing
Rushdie was stabbed about 15 times: in the head, neck, torso and left hand, blinding his right eye and damaging his liver and intestines. (Photo: Getty Images)

Salman Rushdie to release first major work since stabbing

BRITISH-AMERICAN novelist Salman Rushdie will publish his first major work of fiction since the brutal stabbing that blinded him in one eye, his publisher said on Thursday (27).

The Eleventh Hour, is a collection of short stories examining themes and places of interest to Rushdie who narrowly escaped death during the 2022 attack. It will be released on November 4, 2025.

Keep ReadingShow less